C1-INH is an inhibitor of the classical, lectin, and alternative pathway, which additionally interact with the contact and coagulation system, and is currently indicated for the treatment of hereditary angioedema (HAE) [27–29] (Fig. 1). Here, SERPING1 is linked to hereditary angioedema.